platinum has been researched along with Esophageal Squamous Cell Carcinoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 9 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demachi, K; Fujita, T; Fujiwara, H; Kojima, T; Kotani, D; Okunaka, M; Sakashita, S; Yoshino, T | 1 |
| Dong, X; Jia, Y; Song, X; Song, Y; Wang, W; Yi, Y; Zhang, J | 1 |
| Hirota, M; Kawada, J; Kawakami, H; Kii, T; Kurokawa, Y; Matsuyama, J; Nomura, M; Ohta, T; Sakai, D; Satoh, T; Shimokawa, T; Tsujinaka, T | 1 |
| Akimoto, T; Daiko, H; Fujita, T; Fujiwara, H; Hojo, H; Ito, R; Kojima, T; Nakamura, N; Nakamura, Y; Sunakawa, H; Yano, T; Yoshino, T | 1 |
| Bai, Y; Li, E; Qian, J; Shi, D; Xu, J; Xu, N | 1 |
| Gibson, MK; Weidenbaum, C | 1 |
| Wang, CJ; Yin, MM; Zhao, WF; Zhao, Z | 1 |
| Ge, M; Jiang, B; Jiang, W; Song, K; Wang, S; Yan, X; Zhang, L; Zhang, S | 1 |
| Casak, S; Cheng, J; Donoghue, M; Fashoyin-Aje, L; Goldberg, KB; Jiang, X; Khazraee, M; Lemery, S; Liu, J; Mushti, S; Pazdur, R; Pelosof, L; Saung, MT; Theoret, M; Zhao, H | 1 |
| Cheng, L; Wang, M; Wei, Q; Xiang, J; Yu, A; Zhang, R; Zhang, Z; Zhou, F; Zhu, M | 1 |
| Hamaguchi, T; Honma, Y; Iwasa, S; Kato, K; Nagashima, K; Nishikawa, A; Okita, N; Sasaki, Y; Sawada, R; Shimada, Y; Shirakawa, T; Shoji, H; Takahashi, N; Takashima, A; Yamada, Y | 1 |
| Cheng, L; Jia, M; Qiu, L; Wang, M; Wei, Q; Xiang, J; Zhou, F; Zhu, M | 1 |
2 review(s) available for platinum and Esophageal Squamous Cell Carcinoma
| Article | Year |
|---|---|
Efficacy and safety of chemotherapy regimens for first-line treatment of advanced esophageal squamous cell carcinoma in Asia: a systematic review.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Platinum; Prospective Studies; Retrospective Studies; Taxoids | 2022 |
Approach to Localized Squamous Cell Cancer of the Esophagus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Epithelial Cells; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Paclitaxel; Platinum; Quality of Life | 2022 |
2 trial(s) available for platinum and Esophageal Squamous Cell Carcinoma
| Article | Year |
|---|---|
A phase II study of S-1 therapy for patients with advanced and recurrent esophageal cancer resistant or intolerable to fluorouracil, platinum, and taxane therapy (OGSG 1404).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorouracil; Humans; Neoplasm Recurrence, Local; Platinum; Taxoids | 2022 |
Benefit-Risk Summary of Nivolumab for the Treatment of Patients with Unresectable Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma After Prior Fluoropyrimidine- and Platinum-Based Chemotherapy.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Head and Neck Neoplasms; Humans; Nivolumab; Platinum | 2021 |
8 other study(ies) available for platinum and Esophageal Squamous Cell Carcinoma
| Article | Year |
|---|---|
Significance of chemotherapy-free interval and tumor regression grade in patients with recurrent esophageal squamous cell carcinoma receiving chemotherapy with fluorouracil and platinum after esophagectomy following preoperative chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Fluorouracil; Humans; Neoplasm Recurrence, Local; Platinum; Retrospective Studies | 2022 |
Neoadjuvant chemotherapy with liposomal paclitaxel plus platinum for locally advanced esophageal squamous cell cancer: Results from a retrospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Epithelial Cells; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Platinum; Retrospective Studies | 2022 |
Tumor response and survival outcomes of salvage concurrent chemoradiotherapy with three-dimensional conformal radiotherapy and 5-fluorouracil/platinum-based chemotherapy for postoperative locoregional recurrence of esophageal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorouracil; Humans; Neoplasm Recurrence, Local; Platinum; Radiotherapy, Conformal; Retrospective Studies | 2022 |
The efficacy and safety of sintilimab combined with chemotherapy as the first-line treatment for metastatic esophageal squamous cell carcinoma.
Topics: Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Platinum; Retrospective Studies | 2023 |
Cancer cell membrane fused liposomal platinum(IV) prodrugs overcome cisplatin resistance in esophageal squamous cell carcinoma chemotherapy.
Topics: Animals; Cell Line, Tumor; Cell Membrane; Cisplatin; Drug Resistance, Neoplasm; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Platinum; Prodrugs | 2023 |
Genetic variants in nucleotide excision repair pathway predict survival of esophageal squamous cell cancer patients receiving platinum-based chemotherapy.
Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; DNA Repair; Esophageal Squamous Cell Carcinoma; Female; Genetic Association Studies; Genetic Linkage; Genetic Variation; Genotype; Humans; Kaplan-Meier Estimate; Linkage Disequilibrium; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Platinum; Polymorphism, Single Nucleotide; Prognosis; Quantitative Trait Loci; Treatment Outcome | 2018 |
A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Platinum; Prognosis; Pyrimidines; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome | 2014 |
Genetic variants of DNA repair genes predict the survival of patients with esophageal squamous cell cancer receiving platinum-based adjuvant chemotherapy.
Topics: Asian People; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Demography; Disease-Free Survival; DNA Repair; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Genetic Association Studies; Humans; Kaplan-Meier Estimate; Multivariate Analysis; Platinum; Polymorphism, Single Nucleotide; Prognosis; ROC Curve | 2016 |